Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

The Immunology of Macrophage Activation Syndrome.

Crayne CB, Albeituni S, Nichols KE, Cron RQ.

Front Immunol. 2019 Feb 1;10:119. doi: 10.3389/fimmu.2019.00119. eCollection 2019. Review.

2.

Standardizing Terminology and Assessment for Orofacial Conditions in Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-based Recommendations.

Stoustrup P, Resnick CM, Pedersen TK, Abramowicz S, Michelotti A, Küseler A, Verna C, Kellenberger CJ, Nordal EB, Caserta G, Jankovska I, Halbig JM, Kristensen KD, Arvidsson LZ, Spiegel L, Stoll ML, Lerman M, Glerup M, Defabianis P, Frid P, Alstergren P, Cron RQ, Ringold S, Nørholt SE, Peltomäki T, Herlin T, Peacock ZS, Twilt M; TMJ Juvenile Arthritis Working Group.

J Rheumatol. 2019 May;46(5):518-522. doi: 10.3899/jrheum.180785. Epub 2019 Jan 15.

PMID:
30647179
3.

Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.

Crayne CB, Eloseily E, Mannion ML, Azerf SP, Weiser P, Beukelman T, Stoll ML, Feig DI, Prescott Atkinson T, Cron RQ.

Pediatr Rheumatol Online J. 2018 Nov 14;16(1):71. doi: 10.1186/s12969-018-0285-2. Review.

4.

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.

Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ.

Arthritis Rheumatol. 2019 Mar;71(3):451-459. doi: 10.1002/art.40727. Epub 2019 Jan 24.

PMID:
30225949
5.

Risk Factors for Intraarticular Heterotopic Bone Formation in the Temporomandibular Joint in Juvenile Idiopathic Arthritis.

Stoll ML, Amin D, Powell KK, Poholek CH, Strait RH, Aban I, Beukelman T, Young DW, Cron RQ, Waite PD.

J Rheumatol. 2018 Aug;45(9):1301-1307. doi: 10.3899/jrheum.171306. Epub 2018 May 15.

PMID:
29764966
6.

Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?

Stoll ML, Kau CH, Waite PD, Cron RQ.

Pediatr Rheumatol Online J. 2018 Apr 25;16(1):32. doi: 10.1186/s12969-018-0244-y. Review.

7.

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.

Lovell DJ, Johnson AL, Huang B, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Schmidt KM, Mehta J, Wahezi DM, Ting TV, Verbsky JW, Eberhard BA, Spalding S, Chen C, Giannini EH.

Arthritis Rheumatol. 2018 Sep;70(9):1508-1518. doi: 10.1002/art.40509. Epub 2018 Jul 25.

PMID:
29604189
8.

Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis.

Stoll ML, Pierce MK, Watkins JA, Zhang M, Weiss PF, Weiss JE, Elson CO, Cron RQ, Kumar R, Morrow CD, Schoeb TR.

Genes Immun. 2019 Feb;20(2):158-166. doi: 10.1038/s41435-018-0024-1. Epub 2018 Mar 24.

9.

Pediatric rheumatology infusion center: report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year.

Vinod SS, Reed AB, Maxwell J, Cron RQ, Stoll ML.

Pediatr Rheumatol Online J. 2018 Mar 9;16(1):16. doi: 10.1186/s12969-018-0234-0.

10.

Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.

Schulert GS, Zhang M, Husami A, Fall N, Brunner H, Zhang K, Cron RQ, Grom AA.

Arthritis Rheumatol. 2018 Jun;70(6):963-970. doi: 10.1002/art.40438. Epub 2018 May 2.

11.

Age and fecal microbial strain-specific differences in patients with spondyloarthritis.

Stoll ML, Weiss PF, Weiss JE, Nigrovic PA, Edelheit BS, Bridges SL Jr, Danila MI, Spencer CH, Punaro MG, Schikler K, Reiff A, Kumar R, Cron RQ, Morrow CD, Lefkowitz EJ.

Arthritis Res Ther. 2018 Jan 30;20(1):14. doi: 10.1186/s13075-018-1510-6.

12.

Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: a comparative study of children with and without juvenile idiopathic arthritis.

Stoll ML, Guleria S, Mannion ML, Young DW, Royal SA, Cron RQ, Vaid YN.

Pediatr Rheumatol Online J. 2018 Jan 24;16(1):8. doi: 10.1186/s12969-018-0223-3.

13.

Regulatory CD4 T cells inhibit HIV-1 expression of other CD4 T cell subsets via interactions with cell surface regulatory proteins.

Zhang M, Robinson TO, Duverger A, Kutsch O, Heath SL, Cron RQ.

Virology. 2018 Mar;516:21-29. doi: 10.1016/j.virol.2017.12.036. Epub 2018 Jan 8.

14.

Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study.

Stoll ML, Grubbs JA, Beukelman T, Mannion ML, Jester TW, Cron RQ, Crain MJ.

Pediatr Rheumatol Online J. 2017 Nov 9;15(1):79. doi: 10.1186/s12969-017-0207-8.

15.

Isolated Arthritis of the Temporomandibular Joint as the Initial Manifestation of Juvenile Idiopathic Arthritis.

Hügle B, Spiegel L, Hotte J, Wiens S, Herlin T, Cron RQ, Stoll ML, Vinod S, Stoustrup P, Pedersen TK, Twilt M.

J Rheumatol. 2017 Nov;44(11):1632-1635. doi: 10.3899/jrheum.170263. Epub 2017 Sep 1.

PMID:
28864647
16.

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.

Minoia F, Bovis F, Davì S, Insalaco A, Lehmberg K, Shenoi S, Weitzman S, Espada G, Gao YJ, Anton J, Kitoh T, Kasapcopur O, Sanner H, Merino R, Astigarraga I, Alessio M, Jeng M, Chasnyk V, Nichols KE, Huasong Z, Li C, Micalizzi C, Ruperto N, Martini A, Cron RQ, Ravelli A, Horne A; Pediatric Rheumatology International Trials Organization, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.

J Pediatr. 2017 Oct;189:72-78.e3. doi: 10.1016/j.jpeds.2017.06.005. Epub 2017 Aug 12.

PMID:
28807357
17.

Toward Establishing a Standardized Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis.

Tolend MA, Twilt M, Cron RQ, Tzaribachev N, Guleria S, von Kalle T, Koos B, Miller E, Stimec J, Vaid Y, Larheim TA, Herlin T, Spiegel L, Inarejos Clemente EJ, Moineddin R, van Rossum MA, Saurenmann RK, Doria AS, Kellenberger CJ.

Arthritis Care Res (Hoboken). 2018 May;70(5):758-767. doi: 10.1002/acr.23340. Epub 2018 Apr 12.

18.

Malignancy in Pediatric-onset Systemic Lupus Erythematosus.

Bernatsky S, Clarke AE, Zahedi Niaki O, Labrecque J, Schanberg LE, Silverman ED, Hayward K, Imundo L, Brunner HI, Haines KA, Cron RQ, Oen K, Wagner-Weiner L, Rosenberg AM, O'Neil KM, Duffy CM, von Scheven E, Joseph L, Lee JL, Ramsey-Goldman R.

J Rheumatol. 2017 Oct;44(10):1484-1486. doi: 10.3899/jrheum.170179. Epub 2017 Aug 1.

19.

Weathering a Macrophage Storm.

Crayne CB, Cron RQ.

J Rheumatol. 2017 Jul;44(7):970-972. doi: 10.3899/jrheum.170370. No abstract available.

PMID:
28668814
20.

Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.

Schulert GS, Minoia F, Bohnsack J, Cron RQ, Hashad S, KonÉ-Paut I, Kostik M, Lovell D, Maritsi D, Nigrovic PA, Pal P, Ravelli A, Shimizu M, Stanevicha V, Vastert S, Woerner A, de Benedetti F, Grom AA.

Arthritis Care Res (Hoboken). 2018 Mar;70(3):409-419. doi: 10.1002/acr.23277. Epub 2018 Jan 30.

21.

CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.

Robinson TO, Zhang M, Ochsenbauer C, Smythies LE, Cron RQ.

Virology. 2017 Apr;504:79-87. doi: 10.1016/j.virol.2017.01.018. Epub 2017 Jan 31.

22.

Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies.

Stoustrup P, Twilt M, Spiegel L, Kristensen KD, Koos B, Pedersen TK, Küseler A, Cron RQ, Abramowicz S, Verna C, Peltomäki T, Alstergren P, Petty R, Ringold S, Nørholt SE, Saurenmann RK, Herlin T; euroTMjoint Research Network.

J Rheumatol. 2017 Mar;44(3):326-333. doi: 10.3899/jrheum.160796. Epub 2017 Jan 15. Review.

PMID:
28089967
23.

Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors.

Stoll ML, Kumar R, Lefkowitz EJ, Cron RQ, Morrow CD, Barnes S.

Genes Immun. 2016 Dec;17(7):400-405. doi: 10.1038/gene.2016.38. Epub 2016 Oct 27.

24.

Ustekinumab as a Therapeutic Option for Children With Refractory Enthesitis-Related Arthritis.

Mannion ML, McAllister L, Cron RQ, Stoll ML.

J Clin Rheumatol. 2016 Aug;22(5):282-4. doi: 10.1097/RHU.0000000000000408. No abstract available.

PMID:
27464779
25.
26.

The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

Stoll ML, Cron RQ.

Curr Opin Rheumatol. 2016 Sep;28(5):537-43. doi: 10.1097/BOR.0000000000000312. Review.

27.

A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.

Zhang M, Bracaglia C, Prencipe G, Bemrich-Stolz CJ, Beukelman T, Dimmitt RA, Chatham WW, Zhang K, Li H, Walter MR, De Benedetti F, Grom AA, Cron RQ.

J Immunol. 2016 Mar 15;196(6):2492-503. doi: 10.4049/jimmunol.1501284. Epub 2016 Feb 15.

28.

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ; Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society.

Ann Rheum Dis. 2016 Mar;75(3):481-9. doi: 10.1136/annrheumdis-2015-208982.

PMID:
26865703
29.

Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic A, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ.

RMD Open. 2016 Jan 19;2(1):e000161. doi: 10.1136/rmdopen-2015-000161. eCollection 2016.

30.

Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.

Schulert GS, Zhang M, Fall N, Husami A, Kissell D, Hanosh A, Zhang K, Davis K, Jentzen JM, Napolitano L, Siddiqui J, Smith LB, Harms PW, Grom AA, Cron RQ.

J Infect Dis. 2016 Apr 1;213(7):1180-8. doi: 10.1093/infdis/jiv550. Epub 2015 Nov 23.

31.

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.

Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM.

Crit Care Med. 2016 Feb;44(2):275-81. doi: 10.1097/CCM.0000000000001402.

32.

Macrophage Activation Syndrome.

Ravelli A, Davì S, Minoia F, Martini A, Cron RQ.

Hematol Oncol Clin North Am. 2015 Oct;29(5):927-41. doi: 10.1016/j.hoc.2015.06.010. Epub 2015 Aug 25. Review.

PMID:
26461152
33.

Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis.

Stoll ML, Vaid YN, Guleria S, Beukelman T, Waite PD, Cron RQ.

J Rheumatol. 2015 Nov;42(11):2155-9. doi: 10.3899/jrheum.150308. Epub 2015 Sep 1.

PMID:
26329345
34.

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ; Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society.

Arthritis Rheumatol. 2016 Mar;68(3):566-76. doi: 10.1002/art.39332. Epub 2016 Feb 9.

35.

Does Viral Hemorrhagic Fever Represent Reactive Hemophagocytic Syndrome?

Cron RQ, Behrens EM, Shakoory B, Ramanan AV, Chatham WW.

J Rheumatol. 2015 Jul;42(7):1078-80. doi: 10.3899/jrheum.150108. No abstract available.

PMID:
26136549
36.

Clinical features and correct diagnosis of macrophage activation syndrome.

Cron RQ, Davi S, Minoia F, Ravelli A.

Expert Rev Clin Immunol. 2015;11(9):1043-53. doi: 10.1586/1744666X.2015.1058159. Epub 2015 Jun 16. Review.

PMID:
26082353
37.

Kill or be killed.

Behrens EM, Cron RQ.

J Immunol. 2015 Jun 1;194(11):5041-3. doi: 10.4049/jimmunol.1500774. No abstract available.

38.

Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Minoia F, Davì S, Horne A, Bovis F, Demirkaya E, Akikusa J, Ayaz NA, Al-Mayouf SM, Barone P, Bica B, Bolt I, Breda L, De Cunto C, Enciso S, Gallizzi R, Griffin T, Hennon T, Horneff G, Jeng M, Kapovic AM, Lipton JM, Magni Manzoni S, Rumba-Rozenfelde I, Magalhaes CS, Sewairi WM, Stine KC, Vougiouka O, Weaver LK, Davidsone Z, De Inocencio J, Ioseliani M, Lattanzi B, Tezer H, Buoncompagni A, Picco P, Ruperto N, Martini A, Cron RQ, Ravelli A; Pediatric Rheumatology International Trials Organization; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society.

J Rheumatol. 2015 Jun;42(6):994-1001. doi: 10.3899/jrheum.141261. Epub 2015 Apr 15.

PMID:
25877504
39.

Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.

Tambralli A, Beukelman T, Cron RQ, Stoll ML.

J Rheumatol. 2015 Mar;42(3):541-6. doi: 10.3899/jrheum.140863. Epub 2015 Jan 15.

PMID:
25593242
40.

Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis.

Stoll ML, Kumar R, Morrow CD, Lefkowitz EJ, Cui X, Genin A, Cron RQ, Elson CO.

Arthritis Res Ther. 2014 Nov 30;16(6):486. doi: 10.1186/s13075-014-0486-0.

41.

Genetic defects in cytolysis in macrophage activation syndrome.

Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ.

Curr Rheumatol Rep. 2014;16(9):439. doi: 10.1007/s11926-014-0439-2. Review.

PMID:
25086802
42.

Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.

Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao YJ, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; Pediatric Rheumatology International Trials Organization; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society.

Arthritis Rheumatol. 2014 Nov;66(11):3160-9. doi: 10.1002/art.38802.

43.

High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.

Shafferman A, Birmingham JD, Cron RQ.

Pediatr Rheumatol Online J. 2014 Jul 11;12:26. doi: 10.1186/1546-0096-12-26. eCollection 2014.

44.

Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Davì S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite NT, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA, Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D'Angelo G, Eisenstein EM, Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A; Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.

Arthritis Rheumatol. 2014 Oct;66(10):2871-80. doi: 10.1002/art.38769.

45.

The impact of Nucleofection® on the activation state of primary human CD4 T cells.

Zhang M, Ma Z, Selliah N, Weiss G, Genin A, Finkel TH, Cron RQ.

J Immunol Methods. 2014 Jun;408:123-31. doi: 10.1016/j.jim.2014.05.014. Epub 2014 Jun 5.

46.

Treatment of juvenile idiopathic arthritis: a revolution in care.

Stoll ML, Cron RQ.

Pediatr Rheumatol Online J. 2014 Apr 23;12:13. doi: 10.1186/1546-0096-12-13. eCollection 2014. Review.

47.

IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter.

Lowe RM, Genin A, Orgun N, Cron RQ.

Genes Immun. 2014 Apr-May;15(3):137-44. doi: 10.1038/gene.2014.3. Epub 2014 Feb 6.

48.

Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritis.

Foeldvari I, Tzaribachev N, Cron RQ.

Pediatr Rheumatol Online J. 2014 Jan 25;12:6. doi: 10.1186/1546-0096-12-6.

49.

Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.

Shafferman A, Fontaine KR, Cron RQ, Beukelman T.

J Rheumatol. 2014 Jan;41(1):113-8. doi: 10.3899/jrheum.130159. Epub 2013 Dec 1.

PMID:
24293573
50.

Cancer risk in childhood-onset systemic lupus.

Bernatsky S, Clarke AE, Labrecque J, von Scheven E, Schanberg LE, Silverman ED, Brunner HI, Haines KA, Cron RQ, O'Neil KM, Oen K, Rosenberg AM, Duffy CM, Joseph L, Lee JL, Kale M, Turnbull EM, Ramsey-Goldman R.

Arthritis Res Ther. 2013;15(6):R198.

Supplemental Content

Support Center